Active behaviours produced by antidepressants and opioids in the mouse tail suspension test
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Most classical preclinical tests to predict antidepressant activity were initially developed to detect compounds that influenced noradrenergic and/or serotonergic activity, in accordance with the monoaminergic hypothesis of depression. However, central opioid systems are also known to influence the pathophysiology of depression. While the tail suspension test (TST) is very sensitive to several types of antidepressant, the traditional form of scoring the TST does not distinguish between different modes of action. The present study was designed to compare the behavioural effects of classical noradrenergic and/or serotonergic antidepressants in the TST with those of opioids. We developed a sampling technique to differentiate between behaviours in the TST, namely, curling, swinging and immobility. Antidepressants that inhibit noradrenaline and/or serotonin re-uptake (imipramine, venlafaxine, duloxetine, desipramine and citalopram) decreased the immobility of mice, increasing their swinging but with no effect on their curling behaviour. No differences were observed between antidepressants that act on noradrenergic or serotoninergic transmission. While opioid compounds also decreased the immobility of the mice [morphine, codeine, levorphanol, (−)-methadone, (±)-tramadol and (+)-tramadol], they selectively increased curling behaviour. Blocking opioid receptors with naloxone prevented the antidepressant-like effect of codeine, and µ-opioid receptor knockout decreased normal curling behaviour and blocked (±)-tramadol-induced curling, further demonstrating the reliability and validity of this approach. These results show that at least two behaviourally distinct processes occur in the TST, highlighting the antidepressant-like effects of opioids evident in this test. Furthermore, our data suggest that swinging and curling behaviours are mediated by enhanced monoamine and opioid neurotransmission, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534 · cited 1×
“We used a modified form of the TST that was previously validated for NMRI mice (Steru et al. 1985).”
MethodCryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 2×
“A modified form of the rat FST previously described a behavioural sampling technique that could distinguish between antidepressants with noradrenergic and serotonergic modes of action (Cryan et al. 2002).”
BackgroundForced swimming test in mice: A review of antidepressant activity
Petit-Demouliere, B., Chenu, F., & Bourin, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2048-7 · Cited by 1,003 · cited 2×
“Interestingly, and in agreement with previous data regarding the poor effect of SSRIs in animal models of depression (Berrocoso &Mico, 2009a ; Lucki et al. 2001; Petit-Demouliere et al. 2005), a much higher dose of citalopram than that of other classes of antidepressants (noradenergic or dual) is required to significa…”
ResultNeurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Pliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., & Carlezon, W. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07397.2001 · Cited by 509 · cited 2×
“…many studies have described antidepressantlike effects of d (Tejedor-Real et al. 1998 ; Torregrossa et al. 2005, 2006) and k (Mague et al. 2003 ; Pliakas et al. 2001 ; Shirayama et al. 2004) receptor antagonists, the specific roles of these opioid receptors on opioidinduced behaviour was not…”
BackgroundAntidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats
Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C., Jones, R. M., Portoghese, P. S., & Carlezon, W. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046433 · Cited by 485 · cited 2×
“While many studies have described antidepressantlike effects of d (Tejedor-Real et al. 1998 ; Torregrossa et al. 2005, 2006) and k (Mague et al. 2003 ; Pliakas et al. 2001 ; Shirayama et al. 2004) receptor antagonists, the specific roles of these opioid receptors on opioidinduced behaviour was not…”
BackgroundBuprenorphine Treatment of Refractory Depression
Bodkin, J. A., Zornberg, G. L., Lukas, S. E., & Cole, J. O. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199502000-00008 · Cited by 346 · cited 1×
“…in treating some refractory cases of depression such as when using the MOR agonists, oxycodone and oxymorphone, the partial agonist, buprenorphine, and the atypical opioid (¡)-tramadol (Bodkin et al. 1995 ; Fanelli & Montgomery, 1998 ; Shapira et al. 2001 ; Spencer, 2000 ; Stoll & Rueter, 1999).”
Background
Cited by
Opioid receptors: Distinct roles in mood disorders
Lutz, P.-E., & Kieffer, B. L. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.002 · Cited by 542
Ferreira Mello, B. S., Monte, A. S., McIntyre, R. S., Soczynska, J. K., Custódio, C. S., Cordeiro, R. C., Chaves, J. H., Mendes Vasconcelos, S. M., Nobre Júnior, H. V., Florenço de Sousa, F. C., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.06.008 · Cited by 195
“The IMI dose was selected from previous literature evaluating its antidepressant-like effects in mice (Feng et al., 2012; Berrocoso et al., 2013).”
MethodFarzi, A., Reichmann, F., Meinitzer, A., Mayerhofer, R., Jain, P., Hassan, A. M., Fröhlich, E. E., Wagner, K., Painsipp, E., Rinner, B., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.08.011 · Cited by 68
“The mouse was considered curling when the mouse twisted its trunk (Berrocoso et al., 2013).”
Repeated predictable stress causes resilience against colitis-induced behavioral changes in mice
Hassan, A. M., Jain, P., Reichmann, F., Mayerhofer, R., Farzi, A., Schuligoi, R., & Holzer, P. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00386 · Cited by 59
Zhao, J., Niu, C., Wang, J., Yang, H., Du, Y., Wei, L., & Li, C. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s151107 · Cited by 49
Metadata
- Authors
- Berrocoso, E., Ikeda, K., Sora, I., Uhl, G. R., Sánchez-Blázquez, P., & Mico, J. A.
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-02-01
- Volume
- 16
- Issue
- 1
- Pages
- 151-162
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W1997230063
- Cited by
- 95
- References
- 8
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Active behaviours produced by antidepressants and opioids in the mouse tail suspension test. https://app.cochat.ai/papers/10.1017/s1461145711001842
- The paper
- Berrocoso, E., Ikeda, K., Sora, I., Uhl, G. R., Sánchez-Blázquez, P., & Mico, J. A. (2013). Active behaviours produced by antidepressants and opioids in the mouse tail suspension test. International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145711001842
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.